LONDON (Reuters) - Women with mutations in a gene called PALB2 have a one in three chance of developing breast cancer by age 70, according to research that suggests PALB2 is almost as important a risk ...

New research found that the risk of developing breast cancer increased in women who had mutations of a gene related to BRCA2, the PALB2 gene. New research found that the risk of developing breast ...

(CBS News) Mutated versions of a gene called PALB2 can dramatically increase a woman's risk of breast cancer, a new study has found. Women carrying the PALB2 mutation have a one in three chance of ...

Hereditary breast cancer results from inherited mutations, primarily in BRCA1 and BRCA2, increasing lifetime cancer risk. Additional genes like TP53, PTEN, PALB2, CHEK2, and ATM also contribute to ...

Multicenter Prospective Cohort Study of the Diagnostic Yield and Patient Experience of Multiplex Gene Panel Testing For Hereditary Cancer Risk Patients in the mutation-positive group had a median OS ...

The TBCRC-056 trial showed a 50% pCR rate in TNBC patients with BRCA or PALB2 mutations treated with niraparib and dostarlimab. sTILs increased significantly in both treatment arms, with higher ...

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify [email protected] if there are concerns regarding accuracy of the transcription.

The SHARON trial is a phase 1 study testing a new treatment called GO-4 for patients with advanced pancreatic cancer who have ...

Sisters Mary Pat and Susan O'Hern have battled breast cancer multiple times over two decades. A shared PALB2 gene mutation increased their risk for the disease, impacting other family members as well.

In a strange twist of fate, I would not have become a journalist if I had not been diagnosed with breast cancer. I always wanted to work as a journalist and when my three daughters were young, I went ...